Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00987623 · ClinicalTrials.gov registry record · NA

Clinical Evaluation of Two Daily Disposable Lenses in Neophytes

A NA study of Myopia, sponsored by Ciba Vision.

Completed
Registry status
NA
Development phase
326
Enrollment target
1
Study location

NCT00987623: Completed NA study of Myopia, sponsored by Ciba Vision.

NCT00987623 is a NA study of Myopia that has completed, run by Ciba Vision. The registered enrollment target is 326 participants, above the 264-participant average among 90 other Myopia trials with a reported enrollment target (23% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00987623, a NA study of Myopia, has completed, sponsored by Ciba Vision.

COMPLETED
Registry status
NA
Development phase
326 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the performance of two daily disposable contact lenses in a population of neophytes (new wearers).

Conditions Studied

Myopia

Interventions

  • DEVICE nelfilcon A contact lens
  • DEVICE narafilcon A contact lens

Study Locations (1)

Pennsylvania

  • The Research Intelligence Group (TRiG) - Fort Washington

Trial Details

FieldValue
Enrollment Target 326 participants
Start Date 2009-08
Est. Completion 2009-12
Phase NA

Sponsor

Ciba Vision

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00987623

The ClinicalTrials.gov registry entry for NCT00987623 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 326 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 264-participant average among 90 other Myopia trials with a reported enrollment target (23% higher). The listed sponsor is Ciba Vision, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which nelfilcon A contact lens is the first listed.

NCT00987623 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00987623 about?

NCT00987623 is a clinical study titled "Clinical Evaluation of Two Daily Disposable Lenses in Neophytes". The purpose of this study is to evaluate the performance of two daily disposable contact lenses in a population of neophytes (new wearers).

What is the current status of trial NCT00987623?

This trial is currently completed. It is a NA study. The enrollment target is 326 participants. The study started on 2009-08. Estimated completion is 2009-12.

What conditions does trial NCT00987623 study?

This clinical trial studies the following conditions: Myopia.

What interventions are being tested in trial NCT00987623?

The interventions under investigation include: nelfilcon A contact lens (DEVICE), narafilcon A contact lens (DEVICE).

Who is sponsoring clinical trial NCT00987623?

This trial is sponsored by Ciba Vision, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00987623 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Myopia

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.